Madrigal Pharmaceuticals
MDGL
MDGL
135 hedge funds and large institutions have $1.19B invested in Madrigal Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 50 increasing their positions, 31 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
3.02% more ownership
Funds ownership: 58.36% → 61.37% (+3%)
0% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 23
1% less funds holding
Funds holding: 136 → 135 (-1)
Holders
135
Holding in Top 10
3
Calls
$79.4M
Puts
$34.3M
Top Buyers
| 1 | +$53.2M | |
| 2 | +$25.4M | |
| 3 | +$17.7M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$10.6M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$5.64M |
Top Sellers
| 1 | -$48.7M | |
| 2 | -$6.33M | |
| 3 | -$6.17M | |
| 4 |
AG
Artal Group
Luxembourg
|
-$4.38M |
| 5 |
State Street
Boston,
Massachusetts
|
-$4.27M |